Bayer AG (BAYN.DAX30)

Close: 22.99 (+0.51), Apr 25, 2025
Negative

Medium risk

Automatic technical analysis. Medium term, Apr 25, 2025

Bayer AG is in a falling trend channel in the medium long term. This shows that investors over time have sold at lower prices to get out of the stock, and indicates negative development for the company. The stock has met the objective at 21.41 after the break of the rectangle formation. The price has now risen again, but the formation indicates a further fall. The stock has support at Euro 19.00 and resistance at Euro 25.80. Negative volume balance indicates that sellers are aggressive while buyers are passive, and weakens the stock. The stock is overall assessed as technically negative for the medium long term.

Recommendation one to six months: Negative (Score: -82)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.55%86.95+2.27%
5 days56.365.43%70.77+9.71%
22 days-58.7315.44%97.74-4.53%
66 days-26.7930.42%93.00+8.04%

More analyses of Bayer AG

chart Bayer AG (BAYN) Candlesticks 22 Days
Candlesticks
chart Bayer AG (BAYN) Short term
Short term: Positive
chart Bayer AG (BAYN) Medium term
Medium term: Negative
chart Bayer AG (BAYN) Long term
Long term: Negative
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.